Alzheimer's Drug Discovery Foundation
  • Donate
  • Email Sign Up
  • Search
  • Twitter
  • Facebook
  • YouTube
  • About Us
    • Our Founders
    • Staff
    • Leadership
    • Young Professionals Committee
    • Our Impact
    • Our Partners
    • Annual Reports & Financials
    • Careers
  • Alzheimer's Disease
    • What is Alzheimer's?
    • Alzheimer's Causes
    • Diagnosis & Treatment
    • Alzheimer's Prevention
    • Patient & Family Resources
  • Research
    • Our Research Strategy
    • Funding Opportunities
    • Diagnostics Accelerator
    • SpeechDx
    • Goodes Prize
    • Our Portfolio
    • Portfolio Highlights
    • Reporting For Funded Projects
    • Clinical Trials Report
  • Events & Conferences
  • News
    • Announcements
    • Alzheimer's Matters Blog
    • ADDF in the News
  • Ways To Give
    • Corporate Partners
    • Planned Giving
    • Matching Gifts

  • addf access
  • aducanumab
  • agenebio
  • alzecure foundation
  • amylyx
  • amyotrophic lateral sclerosis
  • amyvid™
  • apoe
  • asceneuron
  • axxam
  • batten disease
  • benefit
  • beta-amyloid
  • bill gates
  • biogen
  • biomarkers
  • birax
  • blog
  • caregiving
  • cerebrospinal fluid csf
  • chronic traumatic encephalopathy cte
  • clinical trials
  • cognitive vitality
  • cohbar
  • combination therapy
  • comparative effectiveness
  • concussions
  • conference
  • connoisseur's dinner
  • cypralis
  • diagnostics accelerator
  • drug discovery
  • early-onset alzheimer's
  • epigenetics
  • fall luncheon
  • frontotemporal dementia
  • genetics
  • giving tuesday
  • gliacure
  • great ladies luncheon
  • harrington discovery institute
  • hope on the horizon
  • inflammation
  • klogene therapeutics
  • lewy body dementia
  • ltd.
  • m3 biotechnology
  • medicare
  • melvin r. goodes prize
  • memories matter
  • mild cognitive impairment
  • misfolded proteins
  • mitochondria & metabolic function
  • mri
  • multiple scleroris
  • neuroimaging
  • neurolucent
  • neuroprotection
  • neurotherapia
  • neurotransmitters
  • new staff
  • new trustees
  • nyc marathon
  • oryzon genomics
  • partnership
  • pet scan
  • pharmatrophix
  • policy
  • prevention
  • prion disease
  • proteostasis
  • psychogenics
  • repurposing
  • rexceptor
  • rodin therapeutics
  • runners for alzheimer's research
  • supplements
  • tau
  • tdp-43
  • tetra discovery partners
  • traumatic brain injury
  • vascular
  • vascular dementia
  • venture philanthropy
  • vivreon biosciences
  • world alzheimer's day
  • year in review

Alzheimer's Drug Discovery Foundation

Guide Star

A GuideStar-Rated Charity

57 West 57th Street, Suite 904
New York, NY 10019
info@alzdiscovery.org
212.901.8000

© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).

  • Donate
  • Contact Us
  • 2023 Financials
  • Careers
  • State Disclosures
  • Site Map
  • Terms & Conditions
  • Privacy Policy
Close
  • DONATE
  • SIGN UP
  • Twitter
  • Facebook
  • YouTube
  • About Us
    • Our Founders
    • Staff
    • Leadership
    • Young Professionals Committee
    • Our Impact
    • Our Partners
    • Annual Reports & Financials
    • Careers
  • Alzheimer's Disease
    • What is Alzheimer's?
    • Alzheimer's Causes
    • Diagnosis & Treatment
    • Alzheimer's Prevention
    • Patient & Family Resources
  • Research
    • Our Research Strategy
    • Funding Opportunities
    • Diagnostics Accelerator
    • Melvin R. Goodes Prize
    • Our Portfolio
    • Portfolio Highlights
    • Scientific Resources
    • Clinical Trials Report
    • SpeechDx
  • Events
  • News Room
    • Announcements
    • Alzheimer's Matters Blog
    • ADDF in the News
  • Ways To Give
    • Corporate Partners
    • Planned Giving
    • Matching Gifts
  • Donate
  • Contact Us
  • ADDF in the News
  • Careers
  • Site Map
  • Terms & Conditions
  • Privacy Policy